Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Lessnick

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Pediatric Blood & Cancer|July 28, 2011
Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor StudySteven G DuBois, Robert Goldsby, Mark Segal, et al.
Molecular Cancer Research : MCR|March 17, 2022
Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing SarcomaE John Tokarsky, Jesse C Crow, Lillian M Guenther, et al.
British Journal of Cancer|October 11, 2022
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology GroupDavid S Shulman, Sonja Chen, David Hall, et al.
Oncotarget|February 3, 2017
C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cellsJamie D Gardiner, Lisa M Abegglen, Xiaomeng Huang, et al.
Cancer Genetics|August 8, 2012
Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcomaMona S Jahromi, Angelica R Putnam, Colleen Druzgal, et al.
Nature|June 15, 2007
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channelsNicholas Yagoda, Moritz von Rechenberg, Elma Zaganjor, et al.
Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.
Pediatric Blood & Cancer|December 3, 2014
Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology GroupDaniel M Lerman, Michael J Monument, Elizabeth McIlvaine, et al.
Pediatric Blood & Cancer|May 6, 2008
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor CommitteeJames S Meyer, Helen R Nadel, Neyssa Marina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent MannerMatt L Harlow, Maggie H Chasse, Elissa A Boguslawski, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|July 28, 2011
Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor StudySteven G DuBois, Robert Goldsby, Mark Segal, et al.
Molecular Cancer Research : MCR|March 17, 2022
Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing SarcomaE John Tokarsky, Jesse C Crow, Lillian M Guenther, et al.
British Journal of Cancer|October 11, 2022
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology GroupDavid S Shulman, Sonja Chen, David Hall, et al.
Oncotarget|February 3, 2017
C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cellsJamie D Gardiner, Lisa M Abegglen, Xiaomeng Huang, et al.
Cancer Genetics|August 8, 2012
Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcomaMona S Jahromi, Angelica R Putnam, Colleen Druzgal, et al.
Nature|June 15, 2007
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channelsNicholas Yagoda, Moritz von Rechenberg, Elma Zaganjor, et al.
Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.
Pediatric Blood & Cancer|December 3, 2014
Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology GroupDaniel M Lerman, Michael J Monument, Elizabeth McIlvaine, et al.
Pediatric Blood & Cancer|May 6, 2008
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor CommitteeJames S Meyer, Helen R Nadel, Neyssa Marina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent MannerMatt L Harlow, Maggie H Chasse, Elissa A Boguslawski, et al.
Pageof 10